| Authors: |
Pedersen S; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Colmorn LB; The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Denmark., Ellebaek E; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Kristensen SG; The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Denmark., Ruhlmann C; Department of Oncology, Odense University Hospital, Odense, Denmark., Borch TH; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Fedder J; Center of Andrology & Fertility Clinic, Odense University Hospital, Odense, Denmark., Macklon KT; The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Denmark., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark. Electronic address: inge.marie.svane@regionh.dk. |
